Understand the source comparison
Peptides for Immune Support: Research Compound Comparison
Thymosin Alpha-1 Upregulates IL-2 receptors on T-cells, enhances thymic T-cell maturation ~2 hours 1.6mg SubQ twice weekly Immune reconstitution post-chemotherapy, chronic viral infections Restores impaired T-cell function. No effect in healthy immune systems
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Thymosin Alpha-1
- Upregulates IL-2 receptors on T-cells, enhances thymic T-cell maturation
- ~2 hours
- 1.6mg SubQ twice weekly
- Immune reconstitution post-chemotherapy, chronic viral infections
- Restores impaired T-cell function. No effect in healthy immune systems
- KPV (Lys-Pro-Val)
- Inhibits NF-κB translocation, suppresses inflammatory cytokine transcription
- ~90 minutes
- 500mcg–2mg daily SubQ or oral
- Inflammatory bowel disease, autoimmune inflammation
- Targeted anti-inflammatory. Works only when baseline NF-κB is elevated
- LL-37
- Disrupts microbial membranes via pore formation, modulates neutrophil chemotaxis
- <30 minutes (extended to 4 hours with PEGylation)
- 10–50mcg/mL topical, 2–5mg/kg IV for systemic use
- Wound healing, chronic infections, sepsis models
- Dual antimicrobial and immune-regulating. Requires modified formulation for systemic use